Microbot Medical, Inc. (MBOT)
1.44
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
Microbot Medical Research and Development Expense (Quarterly) : 1.846M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.846M |
| March 31, 2026 | 1.281M |
| December 31, 2025 | 1.532M |
| September 30, 2025 | 1.161M |
| June 30, 2025 | 2.099M |
| March 31, 2025 | 1.444M |
| December 31, 2024 | 1.958M |
| September 30, 2024 | 2.037M |
| June 30, 2024 | 1.403M |
| March 31, 2024 | 1.141M |
| December 31, 2023 | 1.095M |
| September 30, 2023 | 1.612M |
| June 30, 2023 | 1.339M |
| March 31, 2023 | 1.592M |
| December 31, 2022 | 1.851M |
| September 30, 2022 | 1.953M |
| June 30, 2022 | 2.193M |
| March 31, 2022 | 1.706M |
| December 31, 2021 | 2.256M |
| September 30, 2021 | 1.389M |
| June 30, 2021 | 1.389M |
| March 31, 2021 | 1.119M |
| December 31, 2020 | 0.999M |
| September 30, 2020 | 1.037M |
| June 30, 2020 | 0.669M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.691M |
| December 31, 2019 | 0.841M |
| September 30, 2019 | 0.843M |
| June 30, 2019 | 0.741M |
| March 31, 2019 | 0.587M |
| December 31, 2018 | 0.649M |
| September 30, 2018 | 0.623M |
| June 30, 2018 | 0.747M |
| March 31, 2018 | 0.496M |
| December 31, 2017 | 0.20M |
| September 30, 2017 | 0.339M |
| June 30, 2017 | 0.377M |
| March 31, 2017 | 0.182M |
| September 30, 2016 | 0.34M |
| June 30, 2016 | 0.044M |
| March 31, 2016 | 0.216M |
| December 31, 2015 | 5.86M |
| September 30, 2015 | 7.720M |
| June 30, 2015 | 7.239M |
| March 31, 2015 | 6.292M |
| December 31, 2014 | 6.637M |
| September 30, 2014 | 4.658M |
| June 30, 2014 | 6.092M |
| March 31, 2014 | 4.904M |
| December 31, 2013 | 5.981M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| SS Innovations International, Inc. | 2.396M |
| Vicarious Surgical, Inc. | 4.856M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |